In one of his final acts as Senate Majority Leader, Bill Frist (R-TN) overrode the time-honored tradition of senatorial holds, plus members of his own party, and allowed a Senate vote on the President’s nomination of Andrew von Eschenbach to be permanent Commissioner of the Food & Drug Administration. He has been acting commissioner for the past year.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

December 15, 2006 - Table of Contents

NIR December 15, 2006 (full PDF issue)

Pathology Escapes SGR Fee Cut, but Not Other Reductions

CMS Finalizes 2007 Lab Fee Schedule

‘Grandfather’ Protection Extended for Pathology TC Billings

What’s Ahead for Clinical Labs, Pathologists in ’07? A Quick Guide to Key Medicare Policy Changes

New Practice Guideline for HER2 Testing for Breast Cancer

New Waived Tests & Billing Codes

Medicare Recovery Audit Project to Go Nationwide

After Contentious Struggle, FDA Gets Permanent Head